{"id":"W2053290453","doi":"10.1158/1078-0432.ccr-07-0835","title":"Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":true,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Vorinostat; Imatinib mesylate; Sorafenib; Cancer research; Chronic myelogenous leukemia; Histone deacetylase inhibitor; Imatinib; Histone deacetylase; Pharmacology; Biology; Chemistry; Leukemia; Myeloid leukemia; Immunology; Histone; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Falsification/Fabrication of Data;Falsification/Fabrication of Image;Investigation by ORI;Misconduct by Author;","date":"10/1/2016 0:00","openalex_flagged":true},"screen":null}